Regulatory Effects of Cytokines and Cyclosporine A on Peripheral Blood Mononuclear Cs from Stable Multiple Sclerosis Patients

References

• McFarlin D E, McFarland H. Multiple sclerosis. N Engl J Med. 1982; 307: 1183–8
   PubMed Web of Science ®Google Scholar
• Waskman B H, Reynolds W. E. Multiple sclerosis as a disease of immune regulation. Proc SOC Exp Biol Med. 1984; 175: 282–94
   PubMedGoogle Scholar
• Weiner H L, Hauser S. L. Neuroimmunology. I. Immunoregulation in neurological disease. AnnNeurol. 1982; 11: 437–49
   Google Scholar
• Traugott U, Reinherz E L, Raine C. S. Multiple sclerosis: distribution of T-cell subsets within active chronic lesions. Science 1983; 219: 308–10
   PubMed Web of Science ®Google Scholar
• Estes M L, Rudick R A, Barnett G H, Ranshoff R. M. Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging. Arch. Neurol. 1990; 47: 1299–1303
   PubMedGoogle Scholar
• Raine C S, Scheinberg L. C. On the immunopathology of plaque development and repair in multiple sclerosis. J. Neuroimmunol. 1988; 20: 189–201
   PubMedGoogle Scholar
• Zhang J, Markovic-Plese S, Lacet B., et al. Increased fiequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 1994; 179: 973–984
   PubMed Web of Science ®Google Scholar
• Hartung H P, Archelos J J, Zielasek J., et al. Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 1995; 45: S22–S32
   PubMed Web of Science ®Google Scholar
• Trenn G, Kreuzfelder E, Hierholzer E., et al. Age-associated T-lymphocyte activation through mitogens in patients with multiple sclerosis and blood donors. Eur. Neurol. 1988; 28: 47–50
   PubMedGoogle Scholar
• Gallo P, Picino N, Pagni S, Tavolato B. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol. 1988; 24: 795–797
   PubMed Web of Science ®Google Scholar
• Greenberg S J, Marcon L, Hurwitz B. J., et al. Elevated levels of soluble IL-2 receptors in multiple sclerosis (letter). N. Engl. J. Med. 1988; 319: 1019–20
   PubMed Web of Science ®Google Scholar
• Beck J, Rondot P, Catinot L., et al. Increased production of interferon-gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis. Acta Neurol. Scand. 1988; 78: 318–323
   PubMed Web of Science ®Google Scholar
• Sharief M, Thompson E. J. In vivo relationship of tumor necrosis factor-a to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 1992; 38: 27–34
   PubMed Web of Science ®Google Scholar
• Sharief M, Hentges R. Association between tumor necrosis factor and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 1991; 325: 467–472
   PubMed Web of Science ®Google Scholar
• Comabella M. Elevated Interleukin-12 in progressive multiple esclerosis correlates with disease activity and is normalized by pulse cyclophosphamide Therapy. J Clin Invest 1998; 102: 671–8
   PubMed Web of Science ®Google Scholar
• Rieckmann P, Albrecht M, Kitze B., et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 1994; 44: 1523–1526
   PubMed Web of Science ®Google Scholar
• Schluesener H J, Lieder O. Transforming growth factor b1 and b2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T-cell function. J. Neuroimmunol. 1989; 24: 249–258
   PubMed Web of Science ®Google Scholar
• Rott O, Fleisher B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994; 24: 1434–1440
   PubMed Web of Science ®Google Scholar
• Canella B, Raine C. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 1995; 37: 424–435
   PubMedGoogle Scholar
• Weiss A, Imboden J, Hardy K., et al. The role of the T3/antigen receptor complex in T-cell activation. Annv. Rev. Immunol. 1986; 4: 593–619
   PubMed Web of Science ®Google Scholar
• Alcover A, Ramarli D, Richardson N., et al. Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways. Immunol. Rev. 1987; 95: 5–36
   PubMed Web of Science ®Google Scholar
• Hadden J. W. Transmembrane signals in the activation of T-lymphocytes by lectin mitogens. Mol. Immunol. 1988; 25: 1105–1112
   PubMed Web of Science ®Google Scholar
• Fox D A, Schlossman S F, Reinherz E. L. Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody. J. Immunol. 1986; 136: 1945–50
   PubMedGoogle Scholar
• Arai K, Lee F, Miyajima A., et al. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem. 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar
• Balkwill F R, Burke F. The cytokine network. Immunol. Today. 1989; 10: 299–304
   PubMedGoogle Scholar
• Hamilton T A, Adams D. O. Molecular mechanisms of signal transduction in macrophages. Immunol. Today. 1987; 8: 151–8
   PubMedGoogle Scholar
• Stern J B, Smith K. A. Interleukin-2 induction of T cell G1 progression and c-myc expression. Science 1986; 233: 203–206
   PubMed Web of Science ®Google Scholar
• Diamond M S, Springer T. A. The dynamic regulation of integrin adhesiveness. Curr. Biol. 1994; 4: 506–17
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N. The basis of autoimmunity: Part II. Genetic predisposition. Immunol. Today. 1995; 16: 150–158
   PubMedGoogle Scholar
• Peakman M, Vergani D. Autoimmune disease: etiology, therapy and regeneration. Immunol. Today. 1994; 15: 345–347
   PubMedGoogle Scholar
• Girón J A, Alvarez-Mon M, Menendez J. L., et al. T lymphocytes from alcoholic cirrhotic patients show normal interleukin 2 production but a defective proliferative response to polyclonal mitogens. Am. J. Gastroenterol. 1994; 89: 767–73
   PubMedGoogle Scholar
• Pérez-Blás M, Martinez-Martin B, Carballido J., et al. Defective functional response to membrane stimuli in lymphocytes from patients with benign prostatic hyperplasia. Clin. Exp. Immunol. 1995; 101: 521–526
   PubMedGoogle Scholar
• Ford W. L. Lymphocyte migration and immune responses. Prog. Allergy. 1975; 19: 1–59
   PubMedGoogle Scholar
• Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994; 76: 301–14
   PubMed Web of Science ®Google Scholar
• Roman L, Manzano L, De L. a., Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4±CD45RO± phenotype and defective proliferative response in T lymphocytes from patients with Crows disease. Gastroenterol. 1996; 110: 1008–19
   PubMed Web of Science ®Google Scholar
• Menzano L, Alvarez-Mon M, Vargas J. A., et al. Deficient interleukin-2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients. Gut. 1994; 35: 995–960
   Google Scholar
• Poser C M, Paty D W, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis. Guide lines for research protocols. The diagnosis of multiple sclerosis, C. M. Poser. Thieme-Stratton Inc, Stuttgart, New York 1983; 225–229
   Google Scholar
• Boyum A. Isolation on mononuclear cells and granulocytes from human blood. Scand J. Clin. Lab. Invest. 1968; 21: 77–82
   PubMed Web of Science ®Google Scholar
• Fredrikson S. Studies on activation variables in multiple sclerosis. Acta. Neurol. Scand Suppl. 1988; 115: 1–103
   PubMedGoogle Scholar
• Albala M M, Davignon D, Fast L D, Clark D. D. Normal T cell subsets and lymphocyte activity in multiple sclerosis. Clin. Exp. Immunol. 1985; 61: 542–7
   PubMedGoogle Scholar
• Duggan-Keen M, Roberts D F, Bates D. Cell-mediated immunological status in multiple sclerosis patients. Acta. Neurol. Scand. 1986; 73: 408–14
   PubMedGoogle Scholar
• Merrill J E, Mohlstrom C, Uittenbogaart C., et al. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J. Immunol. 1984; 133: 1931–7
   PubMed Web of Science ®Google Scholar
• Glabinski A, Mirecka M, Pokoca L. Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis. Acta. Neurol. Scand. 1995; 91: 276–9
   PubMed Web of Science ®Google Scholar
• Fuleihan R, Ramesh N, Homer A., et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 1994; 93: 1315–1320
   PubMed Web of Science ®Google Scholar